Tunable therapeutic modulation of the gut microbiome by engineered probiotics
通过工程益生菌对肠道微生物组进行可调节的治疗调节
基本信息
- 批准号:9977923
- 负责人:
- 金额:$ 69.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-10 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAmericanArchitectureBasic ScienceBile AcidsBiochemicalBiosensorCecumClassical phenylketonuriaColonCommunitiesComplexDataDevelopmentDiseaseElementsEngineered ProbioticsEngineeringEnvironmentEnzymesFeedbackGastrointestinal DiseasesGastrointestinal tract structureGene ExpressionGenesGoalsHealthHumanImmune System DiseasesImmunologyIn SituKnock-inLibrariesMeasuresMetabolic DiseasesMetagenomicsMicrobeMicrobiologyMotivationMusNutrientPathway interactionsPatientsPhenylalaninePhenylalanine Ammonia-LyasePhenylalanine HydroxylasePhenylketonuriasProbioticsProductionResearchSerumSmall IntestinesStructureTechnologyTemperatureTestingTherapeuticTreatment EfficacyUpdateUrineVolatile Fatty AcidsWorkcolonization resistancecombinatorialdesignefficacy testingenhancing factorexhaustionexperimental studygastrointestinalgene functiongene productgenetic elementgut colonizationgut metagenomegut microbiomegut microbiotahost-microbe interactionsimprovedin vivoinnovationmetabolic engineeringmetagenomemicrobialmicrobial hostmicrobiotamicroorganismmicroorganism interactionmouse modelneurotoxicprobiotic therapypromoterremediationsensorsexsynthetic biologytargeted deliverytherapeutic genetool
项目摘要
ABSTRACT
Engineered probiotics represent a powerful tool with which to ‘knock-in’ gene functions and pathways into the
gut microbiome, alter the structure of the gut microbiome to test hypotheses regarding community architecture
and disease, and to deliver therapeutics. However, known probiotics fail to persist in the gut due to colonization
resistance by the gut microbiota, limiting their value as either research or therapeutic tools. Further, controlled
delivery of therapeutics and other gene products by engineered probiotics is limited by a lack of robust and
tunable synthetic biology tools for the complex in vivo environment. The rationale for the proposed research is
that the promise of probiotic therapies is currently limited by poor persistence and a lack of robust engineering
tools. The central motivation for this proposal is to understand the host and microbial mechanisms governing
probiotic integration and develop tools to engineer probiotic therapies. Guided by strong preliminary data, this
interdisciplinary proposal will pursue three specific aims: to 1) identify determinants of probiotic colonization in
the gut, 2) design and optimize gut-relevant biosensor and expression circuits, and 3) demonstrate the efficacy
of in vivo delivery of a phenylketonuria (PKU) therapeutic by an enhanced probiotic colonizer.
The first aim of this proposal is to optimize and identify mechanisms of probiotic colonization, testing the
hypothesis that probiotic gut colonization is enhanced and tunable by modulating expression of
colonization factors selected from fecal metagenomes. In particular, we will select for durable colonizers
from probiotics expressing an exhaustive combinatorial library of colonization factors driven by in vivo
characterized promoters. The second aim is to develop synthetic biology tools for tunable gene expression
control and biocontainment of engineered probiotics, testing the hypothesis that combining sensors for
temperature, pH, bile acids, and short chain fatty acids will enable spatial control over gene expression
along the gastrointestinal tract. The third aim is to demonstrate that the engineered probiotic chassis can
reliably deliver therapeutics to the gut, testing the hypothesis that our engineered probiotic can stably
deliver phenylalanine-ammonia lyase (Pal2) in a murine model of PKU to decrease serum phenylalanine.
This proposal is innovative because our integrated and complementary research team will improve
understanding of probiotic therapies at both basic science and translational levels. The proposed experiments
are significant in that they will 1) improve our understanding of the genetic elements and microbial interactions
governing gastrointestinal colonization, 2) generate and optimize synthetic biology tools for in vivo circuit control
that will be modular and widely applicable to probiotic engineering, and 3) explore the efficacy of an alternative,
continual-delivery therapeutic for PKU. The proposed research is impactful because it will 1) develop reliable
probiotic colonizers, 2) update the toolbox for synthetic biology in vivo applications, and 3) establish engineered
probiotics as vehicles for sustained therapeutic delivery or controlled modulation of gut community architectures.
摘要
工程益生菌代表了一种强大的工具,可以将基因功能和途径“敲入”到
肠道微生物组,改变肠道微生物组的结构,以测试关于群落结构的假设
and disease疾病,and to deliver交付therapeutic治疗.然而,已知的益生菌由于定植而不能在肠道中持续存在
肠道微生物群的耐药性,限制了它们作为研究或治疗工具的价值。此外,控制
通过工程化益生菌递送治疗剂和其它基因产物受到缺乏稳定和
用于复杂体内环境的可调合成生物学工具。拟议研究的基本原理是
益生菌疗法的前景目前受到持久性差和缺乏强大工程的限制
工具.这项建议的中心动机是了解宿主和微生物的机制,
益生菌整合和开发工具,工程益生菌疗法。在强大的初步数据指导下,
跨学科建议将追求三个具体目标:1)确定益生菌定植的决定因素,
肠道,2)设计和优化肠道相关的生物传感器和表达电路,以及3)证明功效
通过增强的益生菌定殖剂体内递送苯丙酮尿症(PKU)治疗剂。
该提案的第一个目的是优化和识别益生菌定植的机制,测试
假设益生菌肠道定植通过调节
定植因子选自粪便宏基因组。特别是,我们将选择持久的殖民者
来自表达由体内驱动的定殖因子的详尽组合文库的益生菌
特征启动子。第二个目标是开发可调基因表达的合成生物学工具
控制和生物遏制工程益生菌,测试的假设,结合传感器,
温度、pH、胆汁酸和短链脂肪酸将能够对基因表达进行空间控制
沿着胃肠道。第三个目的是证明工程益生菌底盘可以
可靠地将治疗药物输送到肠道,测试我们的工程益生菌可以稳定地
在PKU的鼠模型中递送苯丙氨酸-氨裂解酶(Pal 2)以降低血清苯丙氨酸。
这项建议是创新的,因为我们的综合和互补的研究团队将提高
在基础科学和转化水平上理解益生菌疗法。拟议的实验
重要的是,它们将1)提高我们对遗传因素和微生物相互作用的理解
控制胃肠道定植,2)生成和优化用于体内回路控制的合成生物学工具
这将是模块化的,并广泛适用于益生菌工程,和3)探索替代品的功效,
PKU的持续输送治疗剂。拟议的研究是有影响力的,因为它将1)发展可靠的
益生菌定植者,2)更新合成生物学体内应用的工具箱,以及3)建立工程化的
益生菌作为载体用于持续治疗递送或肠道群落结构的受控调节。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gautam Dantas其他文献
Gautam Dantas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gautam Dantas', 18)}}的其他基金
Impact of early-life perturbations on pediatric microbiome maturation
早期生活扰动对儿科微生物组成熟的影响
- 批准号:
10424578 - 财政年份:2021
- 资助金额:
$ 69.87万 - 项目类别:
Impact of early-life perturbations on pediatric microbiome maturation
早期生活扰动对儿科微生物组成熟的影响
- 批准号:
10298201 - 财政年份:2021
- 资助金额:
$ 69.87万 - 项目类别:
Impact of early-life perturbations on pediatric microbiome maturation
早期生活扰动对儿科微生物组成熟的影响
- 批准号:
10634654 - 财政年份:2021
- 资助金额:
$ 69.87万 - 项目类别:
Occupational Exposure and Health Risk from Dairy Microbiome and Resistome to Dairy Farm Workers
乳制品微生物组和 Resistome 对奶牛场工人的职业暴露和健康风险
- 批准号:
10165408 - 财政年份:2018
- 资助金额:
$ 69.87万 - 项目类别:
Tunable therapeutic modulation of the gut microbiome by engineered probiotics
通过工程益生菌对肠道微生物组进行可调节的治疗调节
- 批准号:
10451749 - 财政年份:2018
- 资助金额:
$ 69.87万 - 项目类别:
Tunable therapeutic modulation of the gut microbiome by engineered probiotics
通过工程益生菌对肠道微生物组进行可调节的治疗调节
- 批准号:
10207474 - 财政年份:2018
- 资助金额:
$ 69.87万 - 项目类别:
Tunable therapeutic modulation of the gut microbiome by engineered probiotics
通过工程益生菌对肠道微生物组进行可调节的治疗调节
- 批准号:
9761466 - 财政年份:2018
- 资助金额:
$ 69.87万 - 项目类别:
PHYLOGENOMIC, TRANSCRIPTOMIC, VIROMIC, AND IMMUNOPROTEOMIC DETERMINANTS OF NECROTIZING ENTEROCOLITIS
坏死性小肠结肠炎的系统基因组、转录组、病毒组和免疫蛋白质组决定因素
- 批准号:
9559708 - 财政年份:2017
- 资助金额:
$ 69.87万 - 项目类别:
PHYLOGENOMIC, TRANSCRIPTOMIC, VIROMIC, AND IMMUNOPROTEOMIC DETERMINANTS OF NECROTIZING ENTEROCOLITIS
坏死性小肠结肠炎的系统基因组、转录组、病毒组和免疫蛋白质组决定因素
- 批准号:
10164835 - 财政年份:2017
- 资助金额:
$ 69.87万 - 项目类别:
PHYLOGENOMIC, TRANSCRIPTOMIC, VIROMIC, AND IMMUNOPROTEOMIC DETERMINANTS OF NECROTIZING ENTEROCOLITIS
坏死性小肠结肠炎的系统基因组、转录组、病毒组和免疫蛋白质组决定因素
- 批准号:
9369551 - 财政年份:2017
- 资助金额:
$ 69.87万 - 项目类别:
相似海外基金
Genetic Architecture of Parkinson's Disease in African-American and Latino Veterans
非裔美国人和拉丁裔退伍军人帕金森病的遗传结构
- 批准号:
10703737 - 财政年份:2023
- 资助金额:
$ 69.87万 - 项目类别:
Metabolic architecture of insulin action in Southwest American Indians
西南美洲印第安人胰岛素作用的代谢结构
- 批准号:
10544900 - 财政年份:2020
- 资助金额:
$ 69.87万 - 项目类别:
Metabolic architecture of insulin action in Southwest American Indians
西南美洲印第安人胰岛素作用的代谢结构
- 批准号:
10647802 - 财政年份:2020
- 资助金额:
$ 69.87万 - 项目类别:
EAGER: Collaborative Research: A Multi-Network Architecture for Expanding Internet Participation and Community-Building on Native American Reservations
EAGER:协作研究:用于扩大美洲原住民保留地的互联网参与和社区建设的多网络架构
- 批准号:
1637265 - 财政年份:2016
- 资助金额:
$ 69.87万 - 项目类别:
Standard Grant
American-derived Western Music in Japan: The Diffusion of the Piano through the Architecture Planned by W. M. Vories
源于美国的西方音乐在日本:钢琴通过 W. M. Vories 规划的建筑的传播
- 批准号:
16K16717 - 财政年份:2016
- 资助金额:
$ 69.87万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Research on the formation and development of modern architecture thought of the American West Coast from the viewpoint of sustainability
可持续视角下美国西海岸现代建筑思想的形成与发展研究
- 批准号:
16K14365 - 财政年份:2016
- 资助金额:
$ 69.87万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
EAGER: Collaborative Research: A Multi-Network Architecture for Expanding Internet Participation and Community-Building on Native American Reservations
EAGER:协作研究:用于扩大美洲原住民保留地的互联网参与和社区建设的多网络架构
- 批准号:
1637280 - 财政年份:2016
- 资助金额:
$ 69.87万 - 项目类别:
Standard Grant
Inter-american materials research on the development and potential applications of novel flexible organic-metal hybrid transistors in vertical architecture
美洲材料研究新型柔性有机金属混合晶体管在垂直结构中的开发和潜在应用
- 批准号:
342227-2007 - 财政年份:2008
- 资助金额:
$ 69.87万 - 项目类别:
Special Research Opportunity Program - Inter-American Collaboration in Materials Research
Inter-american materials research on the development and potential applications of novel flexible organic-metal hybrid transistors in vertical architecture
美洲材料研究新型柔性有机金属混合晶体管在垂直结构中的开发和潜在应用
- 批准号:
342227-2007 - 财政年份:2007
- 资助金额:
$ 69.87万 - 项目类别:
Special Research Opportunity Program - Inter-American Collaboration in Materials Research
Dissertation Research: Regulation in the Architecture of American Modernism, 1890-1920
论文研究:美国现代主义建筑的规定,1890-1920
- 批准号:
0620723 - 财政年份:2006
- 资助金额:
$ 69.87万 - 项目类别:
Standard Grant